IDH1 and glioblastoma: Another finding included decreased levels of butyrate, a neuroprotective gut metabolite (26), in both IDH1-mut and IDH1-WT glioblastoma (Tables 1 and 2), suggesting further investigations on the role of microbial metabolites.